Fig. 8From: Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndromeDisease-free survival of MDS patients with allo-HSCT classified by MF (MF-0/1 VS. MF-2/3)Back to article page